BioElectronics Announces Major Clini...(erica for2004-2005. He is Certified Memb...),Health

Date:5/28/2008

erica for 2004-2005. He is Certified Member of the American Board of Plastic Surgery, a Certified Member of the American Board of Surgery, a Member of the American Society of Plastic Surgeons, a Member of the American Society of Maxillofacial Surgeons, a Member of the International Society of Craniofacial Surgeons, a Member of the Council of Health Care Advisors, and a Member of the American Academy of Anti-Aging Medicine. More information about Dr. Genecov can be seen at http://www.genecovplasticsurgery.com/images/CV_genecov.pdf .

Information on ActiPatch and BioElectronics Corporation is available at the following websites:

-- U.S. Consumer http://www.actipatchonline.com

-- Podiatry: http://www.pemfpodiatry.com

-- Plastic Surgery: http://www.plasticsurgeryrelief.com and http://www.makemeheal.com

-- German orthopedic foot & ankle: http://www.diesfussexperten.de

-- Italy and Switzerland: http://www.actipatch.it

-- Canada: http://www.actipatchpaintherapy.ca

-- Netherlands: http://www.actipatch.de

-- Singapore & Malaysia: http://www.astonixlife.com/

-- BioElectronics Corp: http://www.bioelectronicscorp.com

Safe Harbor Statement

This news release contains forward-looking statements related to future growth and earnings opportunities.
'/>"/>

SOURCE BioElectronics Corp. Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4
Related medicine technology :

1. Cell Therapeutics, Inc. (CTI) Announces Presentations at American Society of Clinical Oncology (ASCO) Annual Meeting
2. Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil
3. Ardea Announces Progress with HIV Non-Nucleoside Reverse Transcriptase Inhibitor Program
4. Novavax Announces Proprietary Method to Create SARS Vaccine and Renewal of NIH Funding for SARS Vaccine Development
5. BARC Announces Long-Term Cooperation In South African Biobanking for HIV Vaccine Trials
6. Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder
7. QuatRx Pharmaceuticals Announces Presentation of Further Data from Ophena(TM) (Ospemifene) Phase 3 Study for Treatment of Symptoms of Vulvovaginal Atrophy
8. Alba Therapeutics Announces the Presentation of Results of a Phase IIa Clinical Trial for Larazotide Acetate for the Treatment of Celiac Disease at the Digestive Disease Week Conference
9. PTC Therapeutics Announces Data Supporting Cough Frequency as a New Outcome Measure in Evaluating Treatments for Cystic Fibrosis
10. Telik Announces Initiation of Two Phase 2 Randomized TELINTRA Studies
11. Omeros Announces Initiation of Patient Enrollment in OMS201 Phase 1 Study